Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ameae M Walker

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Expert Opinion on Investigational Drugs|September 23, 2006
Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulatorAmeae M Walker
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
Prolactin receptor antagonistsAmeae M Walker
Molecular and Cellular Endocrinology|August 3, 2007
S179D prolactin: antagonistic agony!Ameae M Walker
Journal of Molecular Endocrinology|November 13, 2009
Short form 1b human prolactin receptor down-regulates expression of the long formDunyong Tan, Ameae M Walker
Cancer|December 3, 2005
Human chorionic gonadotropin beta (HCGbeta) down-regulates E-cadherin and promotes human prostate carcinoma cell migration and invasionWei Wu, Ameae M Walker
Journal of Mammary Gland Biology and Neoplasia|December 1, 2016
Role of Prolactin in Promotion of Immune Cell Migration into the Mammary GlandRiva Dill, Ameae M Walker
Vitamins and Hormones|August 14, 2025
B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptorSrividya Swaminathan, Ameae M Walker
Journal of Cellular Immunology|August 18, 2025
The Ability of Neonatal Mice to Develop Immunity to <i>Mycobacterium tuberculosis</i> Shows Sex Differences, with Females Displaying Evidence of an Enhanced Immune ResponseMrinal K Ghosh, Ameae M Walker
Genes & Cancer|September 2, 2022
Splice modulating oligomers as cancer therapeuticsKuanHui E Chen, Ameae M Walker
The Prostate|September 10, 2009
Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacityKuang-tzu Huang, Ameae M Walker
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|September 23, 2006
Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulatorAmeae M Walker
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
Prolactin receptor antagonistsAmeae M Walker
Molecular and Cellular Endocrinology|August 3, 2007
S179D prolactin: antagonistic agony!Ameae M Walker
Journal of Molecular Endocrinology|November 13, 2009
Short form 1b human prolactin receptor down-regulates expression of the long formDunyong Tan, Ameae M Walker
Cancer|December 3, 2005
Human chorionic gonadotropin beta (HCGbeta) down-regulates E-cadherin and promotes human prostate carcinoma cell migration and invasionWei Wu, Ameae M Walker
Journal of Mammary Gland Biology and Neoplasia|December 1, 2016
Role of Prolactin in Promotion of Immune Cell Migration into the Mammary GlandRiva Dill, Ameae M Walker
Vitamins and Hormones|August 14, 2025
B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptorSrividya Swaminathan, Ameae M Walker
Journal of Cellular Immunology|August 18, 2025
The Ability of Neonatal Mice to Develop Immunity to <i>Mycobacterium tuberculosis</i> Shows Sex Differences, with Females Displaying Evidence of an Enhanced Immune ResponseMrinal K Ghosh, Ameae M Walker
Genes & Cancer|September 2, 2022
Splice modulating oligomers as cancer therapeuticsKuanHui E Chen, Ameae M Walker
The Prostate|September 10, 2009
Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacityKuang-tzu Huang, Ameae M Walker
Pageof 7